Bernhard Muellinger

457 total citations
11 papers, 280 citations indexed

About

Bernhard Muellinger is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Bernhard Muellinger has authored 11 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 2 papers in Oncology. Recurrent topics in Bernhard Muellinger's work include Inhalation and Respiratory Drug Delivery (8 papers), Respiratory viral infections research (2 papers) and Pneumonia and Respiratory Infections (2 papers). Bernhard Muellinger is often cited by papers focused on Inhalation and Respiratory Drug Delivery (8 papers), Respiratory viral infections research (2 papers) and Pneumonia and Respiratory Infections (2 papers). Bernhard Muellinger collaborates with scholars based in Germany, United States and United Kingdom. Bernhard Muellinger's co-authors include Norbert Weber, Karl Haeußinger, Loems Ziegler‐Heitbrock, Jie Li, Gabriela Apiou-Sbirlea, Barbara Rothen‐Rutishauser, Stéphan Ehrmann, Marine Pichelin, Livia Tossici-Bolt and P. A. Dailey and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

Bernhard Muellinger

11 papers receiving 275 citations

Peers

Bernhard Muellinger
Michael DePietro United States
Sandra Scott United Kingdom
Vesna Čukić Bosnia and Herzegovina
Bernhard Muellinger
Citations per year, relative to Bernhard Muellinger Bernhard Muellinger (= 1×) peers Daniel Grimbert

Countries citing papers authored by Bernhard Muellinger

Since Specialization
Citations

This map shows the geographic impact of Bernhard Muellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Muellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Muellinger more than expected).

Fields of papers citing papers by Bernhard Muellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Muellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Muellinger. The network helps show where Bernhard Muellinger may publish in the future.

Co-authorship network of co-authors of Bernhard Muellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Muellinger. A scholar is included among the top collaborators of Bernhard Muellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Muellinger. Bernhard Muellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wong, Chun Yuen Jerry, Bernhard Muellinger, W. Nijdam, et al.. (2023). Advances in soft mist inhalers. Expert Opinion on Drug Delivery. 20(8). 1055–1070. 32 indexed citations
2.
Fink, James B., Stéphan Ehrmann, Jie Li, et al.. (2020). Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(6). 300–304. 77 indexed citations
3.
Campo, Ilaria, Francesca Mariani, Elena Paracchini, et al.. (2016). Whole Lung Lavage Followed By Inhaled Sargramostim As Therapy Of Autoimmune Pulmonary Alveolar ProteINOSis. American Journal of Respiratory and Critical Care Medicine. 3 indexed citations
4.
Campo, Ilaria, Francesca Mariani, Elena Paracchini, et al.. (2016). Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP). PA3870–PA3870. 11 indexed citations
5.
Vogelmeier, Claus, Péter Kardos, Thomas Hofmann, et al.. (2014). Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. European Respiratory Journal. 45(5). 1273–1282. 16 indexed citations
6.
Fleming, John, Joy Conway, Caroline Majoral, et al.. (2010). The Use of Combined Single Photon Emission Computed Tomography and X-ray Computed Tomography to Assess the Fate of Inhaled Aerosol. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24(1). 49–60. 54 indexed citations
7.
Luisetti, Maurizio, Takuji Suzuki, Zamir Kadija, et al.. (2010). Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer. Pulmonary Pharmacology & Therapeutics. 24(1). 123–127. 22 indexed citations
8.
Hein, Stephanie, et al.. (2010). The Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) In Vitro System: Design and Experimental Protocol. Alternatives to Laboratory Animals. 38(4). 285–295. 24 indexed citations
9.
Muellinger, Bernhard, et al.. (2006). Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease. Vaccine. 24(31-32). 5832–5838. 19 indexed citations
10.
Muellinger, Bernhard, et al.. (2006). Lung deposition of aerosolized anticancer drugs with a novel inhalation system: AKITA. Journal of Clinical Oncology. 24(18_suppl). 12037–12037. 2 indexed citations
11.
Muellinger, Bernhard, et al.. (2005). Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers. Vaccine. 23(43). 5113–5119. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026